Xiao-I Corporation, a Shanghai-founded artificial intelligence company that trades on the Nasdaq Global Market as American Depositary Shares under the ticker AIXI, received a delisting warning on August 6, 2026, when the exchange notified it that the market value of its publicly held shares had fallen below the fifteen-million-dollar threshold required for continued listing, giving the company until February 1, 2027 to repair the shortfall. The warning arrives after a bruising fiscal 2025 in which revenue collapsed by more than eighty percent to just over twelve million dollars, the balance sheet flipped to a shareholders' deficit of roughly 105 million dollars, and auditors attached a going-concern qualification to the annual financial statements. The August notice is not an isolated event but the latest turn in a repeated cycle of dilutive financing, reverse-split mechanics, and listing-repair efforts that has defined the company since its public debut.
The thesis that emerges from the filings is that Xiao-I's equity is best understood not as a growth story but as a survival and option trade, one where the entire investable question reduces to whether the company can keep its Nasdaq listing alive long enough to monetize its one genuine asset, a portfolio of Chinese artificial-intelligence patents that it has spent more than a decade enforcing against Apple. The market appears to be pricing the ordinary shares, which now trade for roughly one and a half cents each after a twenty-for-one reverse split in May 2026, as a claim on that patent litigation and little else, because the operating business has shrunk to the point where it generated just over twelve million dollars of revenue in 2025 and consumed most of its modest cash reserve growing that base. What the equity is missing, in our view, is a clear view of how long the current financing treadmill can run.
The single load-bearing risk is that the company cannot regain the fifteen-million-dollar market-value requirement by February 2027, which would open the door to a Nasdaq delisting, and that the convertible notes it keeps issuing to fund operations accelerate the dilution that pushes the requirement further out of reach. The falsifiable clock is the company's next semi-annual financial update, which should reveal whether revenue stabilized or contracted further and whether the recurring maintenance-and-support base, the only revenue line that grew in 2025, can carry the cost structure while the patent litigation against Apple plays out in the Chinese appellate courts.